From a problem to a business opportunity-design of pharmaceuticals for environmental biodegradability

Research output: Journal contributionsScientific review articlesResearch


Research of the past 20 years has demonstrated that human and veterinary pharmaceuticals are present in the environment. In addition to the parent compounds also metabolites and other transformation products formed within treatment or in the environment have been detected. In order to overcome the shortcomings of effluent and manure treatment new active compounds were designed for complete mineralization in the environment.

Original languageEnglish
Article number100136
JournalSustainable Chemistry and Pharmacy
Number of pages4
Publication statusPublished - 06.2019

Bibliographical note

The author wants to thank the involved co-workers and the Deutsche Bundesstiftung Umwelt for supporting the work with GSF (Grant 22597-31 ) and the derivatives of ciprofloxacin (Grant 30839) and the Bundesministerium for Bildung und Forschung for supporting (Grant 03X9410 ) the work with the ß-blockers.